Losartan potassium tablets are used for hypertensive patients, and it can also treat nephropathy in Type 2 diabetic patients. Torrent Pharmaceuticals Limited decided to voluntarily recall two lots of these meds. That is because an impurity has been found in them, and it is believed that it can cause cancer.
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification,” read the FDA announcement. w
Luckily, as soon as the discovery was made, the meds were recalled. Lots 30, 90 and 1000 count bottles are being recalled, and they all expire on April 2019. If you have already purchased any of these it is advised that you contact a physician or a pharmacist. You should continue to take your medication, so you will need an alternative treatment until you can use this one again.
Fortunately, there haven’t been any adverse incidents so far. If you have any questions or if you want to report any adverse reactions, you should contact Torrent Pharmaceuticals Limited. Their phone number is 1-800-912-9561. For live calls you need to call between 8 am and 5 pm, Eastern Time, and you can leave a voicemail message at any time. You might also need to contact your physician if you are experiencing any problems.